在卵巢刺激期间相对雌激醇变化的影响,在辅助生殖技术中的胚胎细胞形成和活产
Wenjie Huang1,2, Liuyan Wei3, Juan Tang3
1Department of Reproductive Medicine, Guangzhou Women and Children's Medical center Liuzhou Hospital, Liuzhou, Guangxi, China. a17377552242@163.com.
Scientific reports
|May 4, 2025
概括
在受控卵巢刺激 (COS) 期间,更高的雌激素 (E2) 水平显著改善了辅助生殖技术 (ART) 中的胚胎发育和怀孕成功率. 这项研究强调了E2反应在ART周期中获得更好的结果的预测价值.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 辅助生殖技术 辅助生殖技术
- 临床胚胎学 临床胚胎学
背景情况:
- 在辅助生殖技术 (ART) 中,在受控卵巢刺激 (COS) 期间,雌激素 (E2) 水平至关重要.
- 相对E2变化对ART结果的预测值需要进一步阐明.
研究的目的:
- 评估COS和胚胎发育期间E2水平的相对变化之间的关联.
- 评估E2反应对临床怀孕和活产率在ART中的影响.
主要方法:
- 追溯分析了9376次第一个新鲜的ART周期 (2020年1月 - 2022年12月).
- 根据COS期间相对E2水平变化,患者被分为四组.
- 主要结局:胚芽细胞形成率,临床怀孕率,活产率. 二次结果:流产和异胎妊娠率.
主要成果:
- 在E2反应较高的群体中,胚胎细胞形成率显著增加 (P < 0.001).
- 与低响应组相比,中度高和高E2响应组显示出显著更高的临床怀孕和活产率.
- 在中度和低E2响应组之间没有观察到怀孕结果的显著差异. 两组之间流产或异胎妊娠率没有显著差异.
结论:
- 在COS期间E2水平的相对增加是改善胚胎发育的重要预测因素.
- 较高的E2反应与ART的临床怀孕和活产率的增强有关.
- 在COS期间监测E2动态可以帮助预测ART成功.
相关概念视频
In Vitro Fertilization
147
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
147
Oogenesis
63.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.1K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


